Outcome of patient undergoing redo mitral valve surgery with incidence rate of mitral valve infective endocarditis
Journal of Cardiothoracic Surgery · 2024
DOI: 10.1186/s13019-024-03063-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiothoracic Surgery, 2024. Verfasst von Basel A Jobeir und 9 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center, King Faisal Specialist Hospital & Research Center (KFSHRC), PO Box 3354, Riyadh, 11211, Saudi Arabia. Hauptthemen laut MEDLINE: Reoperation, Mitral Valve, Endocarditis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: The incidence of infective endocarditis (IE) in patients undergoing redo mitral valve (MV) surgery was evaluated. The outcomes of all the patients and the patients' specific characteristics were recorded. The patients were analyzed to further the research of IE in this population. METHOD: This was a retrospective review of patients admitted for redo MV surgery with a prospective follow-up of electronic medical records at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia, from 2009 to 2019. Pre/intra/post-operative factors contributing to mortality, morbidity, and freedom of adverse events were analyzed. RESULT: A total of 211 patients underwent redo MV surgery, and 41 patients (19.4%) had IE; and 51% of this subset of patients, 21 individuals, developed IE after the initial MV surgery. MV stenosis was moderate/severe in 50 patients. Furthermore, MV regurgitation was present in 89 patients. Multivariate analysis of the data revealed multiple factors influencing mortality: age, peripheral vascular disease, concomitant procedures, peripheral vascular disease, red blood cell transfusions, preoperative mechanical valves, and active IE. In-hospital Mortality was 10.9%. The one-, five-, and ten-year survival was 88%, 79%, and 69% across all patients. CONCLUSION: Although redo MV surgery has acceptable outcomes; the presence of IE or concomitant procedures is a significant health detriment in these patients. Our study highlights the need for careful patient management and more in-depth research in this area to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Heart Center, King Faisal Specialist Hospital & Research Center (KFSHRC), PO Box 3354, Riyadh, 11211, Saudi Arabia.
- College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
- Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Heart Center, King Faisal Specialist Hospital & Research Center (KFSHRC), PO Box 3354, Riyadh, 11211, Saudi Arabia. F.Khaliel@doctor.com.
Zitieren
APA
Jobeir, B. A., De Vol, A. E., Alanazi, Z. M., Galzerano, D., Jobeir, A. A., Alsanei, A. M., Alamro, B., Alamri, M., AlHalees, Z. Y., & Khaliel, F. H. (2024). Outcome of patient undergoing redo mitral valve surgery with incidence rate of mitral valve infective endocarditis. Journal of Cardiothoracic Surgery. https://doi.org/10.1186/s13019-024-03063-5
Vancouver
Jobeir BA, De Vol AE, Alanazi ZM, Galzerano D, Jobeir AA, Alsanei AM, et al. Outcome of patient undergoing redo mitral valve surgery with incidence rate of mitral valve infective endocarditis. Journal of Cardiothoracic Surgery. 2024. doi:10.1186/s13019-024-03063-5
BibTeX
@article{Jobeir2024,
author = {Jobeir, Basel A and De Vol, Abdelkarim E and Alanazi, Ziyad M and Galzerano, Domenico and Jobeir, Anas A and Alsanei, Aly M and Alamro, Bandar and Alamri, Mohammed and AlHalees, Zohair Y and Khaliel, Feras H},
title = {Outcome of patient undergoing redo mitral valve surgery with incidence rate of mitral valve infective endocarditis},
journal = {Journal of Cardiothoracic Surgery},
year = {2024},
doi = {10.1186/s13019-024-03063-5}
}
EUVIMED